SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,823,358 | +18.5% | 84,013 | +7.5% | 0.10% | +23.5% |
| Q2 2023 | $15,039,017 | +13.6% | 78,141 | +19.5% | 0.08% | -5.6% |
| Q1 2023 | $13,239,311 | +3.5% | 65,389 | -34.3% | 0.09% | -15.9% |
| Q4 2022 | $12,789,058 | +1.8% | 99,518 | +8.4% | 0.11% | -20.1% |
| Q3 2022 | $12,561,000 | +6.9% | 91,803 | +38.3% | 0.13% | +24.1% |
| Q2 2022 | $11,749,000 | -4.1% | 66,401 | -21.9% | 0.11% | +47.9% |
| Q1 2022 | $12,250,000 | +23.0% | 85,040 | +32.0% | 0.07% | +40.4% |
| Q4 2021 | $9,961,000 | +23.4% | 64,433 | +35.6% | 0.05% | -5.5% |
| Q3 2021 | $8,071,000 | +27.6% | 47,534 | +18.6% | 0.06% | +37.5% |
| Q2 2021 | $6,326,000 | -1.9% | 40,067 | -13.7% | 0.04% | -9.1% |
| Q1 2021 | $6,447,000 | +57.6% | 46,426 | +98.7% | 0.04% | +10.0% |
| Q4 2020 | $4,091,000 | – | 23,361 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |